iFAST Corporation (SGX: AIY) continues its impressive trajectory, reporting a robust performance in the second quarter of 2025.
Revenue surged by 28% year-on-year (YOY) to S$120 million, while net profit soared by almost 38% YOY to over S$22 million.
This strong growth was a collective effort across all geographical segments. Notably, Hong Kong accounted for over half of the profits, driven by its burgeoning ePension business.
Adding to this positive momentum, iFAST Global Bank (iGB) maintained its profitable streak since 4Q 2024, contributing S$0.70 million in profit for the quarter.
As if these achievements weren’t enough, iFAST anticipates an even stronger second half of the year.
Further sweetening the deal for shareholders, the company has proposed an S$0.02 dividend per share for this quarter, 33% higher YOY, and expected total dividend of S$0.08 for the full financial year (FY) 2025.
While iFAST has provided a comprehensive presentation of this quarter’s results (which you can access here), my aim is not to reiterate those details.
Instead, I’d like to share my insights on these latest results and iFAST’s future price potential.
Strong business momentum, volatile short-term price movement
You might recall iFAST’s share price plunged by 12% after its 1Q 2025 results.
This wasn’t due to poor performance – revenue and profit were up 24% and 31% YOY, respectively.
Rather, the market reacted negatively to the revised 2025 profit before tax (PBT) target for the Hong Kong segment, lowered from an initial HK$500million to HK$380 million.
To me, this reaction was irrational, given the company’s underlying robust performance. With this stronger second quarter and an even better second half anticipated, I’m pleased to see my assessment validated.
While I’d love to see the stock price soar when the market re-opens next Monday (especially since I’m not increasing my positions further), we all know the market doesn’t care about individual expectations.
There’s no point second-guessing short-term price movements.
My confidence lies firmly in iFAST’s longer-term price trajectory. As long as iFAST continues to execute its strategies effectively, its stock price will eventually be re-rated.
My assumptions and projections
Please note: The following is my personal projection and should not be construed as financial advice.
Based on the results, iFAST’s 1H 2025 earnings per share (EPS) stands at S$0.1368. Given the guidance of a stronger second half, it’s reasonable to expect EPS to be at least S$0.30 for the FY 2025.
Consequently, at its current price of S$7.42, iFAST is trading at a price-to-earnings (P/E) ratio of approximately 25x.
A glance at historical data (as shown in the chart below) reveals that iFAST has traded at a wide P/E range, from 28x to 148x, over the past decade.
Interestingly, its share price volatility isn’t solely attributable to its underlying fundamentals.
While the P/E spike in 2022 was indeed a result of the share price plunge (caused by broad market weakness and the impairment of its India Business), the share price continued to languish even in the subsequent year, despite iFAST posting a strong recovery.
Excluding these exceptional years, it’s fair to say the market typically values iFAST at a P/E of around 30x.
So, is the current P/E of 25x cheap?
There’s no straightforward answer, as it entirely depends on your conviction regarding iFAST’s ability to deliver sustained double-digit growth going forward.
If iFAST can achieve just 20% growth for the next three years, its EPS could exceed S$0.50. Consequently, its stock price would likely climb north of S$10.
Obviously, this is not guaranteed.
While I remain confident in management’s competency in steering iFAST’s growth, missteps such as the impairment of the India Business or lowered projections for the HK segment could still occur.
Hence, despite my excitement for iGB’s potential, I am prudently limiting my current exposure, which is approaching 8% of my total portfolio.
Discover more from The Fat Investor
Subscribe to get the latest posts sent to your email.